Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Český Krumlov

7 clinical trials in Český Krumlov, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Český Krumlov at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Český Krumlov

Open in trial search

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Type 2 diabetes mellitus+2

Not recruiting

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Český Krumlov

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on lipoprotein management and cardiovascular event prevention. Research examines new therapeutic approaches for patients with established cardiovascular disease.

  • Major cardiovascular events prevention
  • Lipid management therapies
  • Cardiovascular risk reduction

Advanced clinical investigations evaluating novel compounds for improving cardiovascular outcomes.

02 Metabolic Disorders

Comprehensive research targeting multiple metabolic conditions, including Type 2 Diabetes and obesity management. Studies evaluate innovative treatments for weight control.

  • Weight management therapies
  • Diabetes treatment
  • Metabolic health optimization

Trials focus on developing effective interventions for patients with concurrent metabolic conditions.

03 Preventive Cardiology

Groundbreaking research in primary prevention of atherosclerotic cardiovascular disease. Studies evaluate novel approaches to prevent major adverse cardiovascular events.

  • ASCVD prevention strategies
  • Cardiovascular risk management
  • Preventive interventions

Clinical investigations aim to reduce cardiovascular risks in high-risk populations through innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.